Researchers have unveiled a novel approach to tackle obesity by targeting fat absorption in the small intestine. The ...

The FDA decision will enable Antag Therapeutics to initiate the clinical development of its lead candidate drug, a ...

An obesity expert weighs in on intriguing new data and new drugs that hold promise in the battle against a stubborn problem.

A recent CDC report indicated that the U.S. obesity rates may have dropped after over a decade-long rise last year, a finding ...

Newly released data shows that the U.S. may have reached peak obesity in 2020 — and the timing unsurprisingly coincides with ...

Eli Lilly and Novo Nordisk are spending billions to find new ... like obesity or diabetes, if it ever happens. September has been an intense month so far for R&D dealmaking for genetic drugs.

Meanwhile, thousands of patients allege in a lawsuit that drugs used for diabetes and weight loss have caused other health problems. The Washington Post: FDA Approves New Type Of Antipsychotic ...

WeightWatchers has struggled against competition from new “GLP-1” weight loss drugs such as Eli Lilly ... 97 per cent of their value since mid-2021. Thilo Semmelbauer, chair of the company ...

Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in decades. The drug, called Cobenfy and developed by US pharma giant ...

(SILVER SPRING, Md.) — The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in more than 30 years. Cobenfy, manufactured by ...

But a recent study found that nearly 80% of teens seeking treatment for obesity reported symptoms ... helping a teen lose weight with these new drugs, which suppress appetite and alter metabolism ...

The medication, Cobenfy, combines two drugs and is taken as a twice-daily pill. The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with ...